ZS801
IIT2021057（ZS801-02）
Unknown gene_therapy active
Quick answer
ZS801 for Hemophilia B is a Unknown program (gene_therapy) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Hemophilia B
- Phase
- Unknown
- Modality
- gene_therapy
- Status
- active